Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure
Author(s) -
Guillaume Duthoit,
Johanne Silvain,
Éloi Marijon,
Grégory Ducrocq,
Antoine Lepillier,
Corinne Frère,
Solohaja-Faniaha Dimby,
Batric Popovic,
Nicolas Lellouche,
Isabelle MartinToutain,
Christian Spaulding,
Éric Brochet,
David Attias,
Jacques Mansourati,
Luc Lorgis,
Didier Klug,
N. Zannad,
Marie HauguelMoreau,
N. Braïk,
S. Deltour,
Alexandre Ceccaldi,
Hui Wang,
Nadjib Hammoudi,
Delphine Brugier,
Éric Vicaut,
JeanMichel Juliard,
Gilles Montalescot
Publication year - 2020
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.119.008481
Subject(s) - medicine , rivaroxaban , atrial fibrillation , interquartile range , clopidogrel , cardiology , clinical endpoint , aspirin , anesthesia , randomized controlled trial , warfarin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom